Representative Dan Newhouse (Republican-Washington) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on July 17th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on July 10th. The trade occurred in the Representative’s “EDWARD JONES IRA” account.
Representative Dan Newhouse also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Costco Wholesale (NASDAQ:COST) on 7/10/2026.
- Sold $1,001 – $15,000 in shares of Deere & Company (NYSE:DE) on 7/10/2026.
- Purchased $1,001 – $15,000 in shares of Arista Networks (NYSE:ANET) on 7/10/2026.
- Sold $1,001 – $15,000 in shares of United Parcel Service (NYSE:UPS) on 7/10/2026.
- Sold $1,001 – $15,000 in shares of Hershey (NYSE:HSY) on 7/10/2026.
- Purchased $1,001 – $15,000 in shares of Duke Energy (NYSE:DUK) on 7/10/2026.
- Purchased $1,001 – $15,000 in shares of Amcor (NYSE:AMCR) on 7/10/2026.
- Sold $1,001 – $15,000 in shares of Fortinet (NASDAQ:FTNT) on 7/10/2026.
- Sold $1,001 – $15,000 in shares of Magna International (NYSE:MGA) on 7/10/2026.
- Purchased $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 7/10/2026.
UnitedHealth Group Trading Down 1.0%
Shares of UNH opened at $421.84 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $461.62. The company has a 50 day simple moving average of $405.55 and a two-hundred day simple moving average of $343.00. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80. The firm has a market cap of $383.09 billion, a P/E ratio of 27.15, a price-to-earnings-growth ratio of 1.67 and a beta of 0.62.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is currently 59.72%.
Key Headlines Impacting UnitedHealth Group
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: UnitedHealth announced a $5 billion share buyback, which investors may view as a sign management is confident in the company’s cash flow and recovery path. A $5 Billion Reason to Buy UnitedHealth Stock Here
- Positive Sentiment: Barclays raised its price target on UNH to $441 from $429 and kept an overweight rating, reinforcing the view that shares still have upside from current levels. Barclays Raises Price Target on UnitedHealth
- Positive Sentiment: Several firms, including Truist, Oppenheimer, and KeyBanc, reportedly boosted targets to $500 after a strong second quarter, with analysts saying UnitedHealth “handily” beat expectations and still has room to run. UNH Stock Tracks Hot Monthly Streak
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.19% of the stock is owned by corporate insiders.
Hedge Funds Weigh In On UnitedHealth Group
Several hedge funds have recently bought and sold shares of UNH. Walker Asset Management LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $229,000. Ballast Inc. increased its stake in UnitedHealth Group by 11.4% in the second quarter. Ballast Inc. now owns 17,484 shares of the healthcare conglomerate’s stock valued at $7,267,000 after purchasing an additional 1,791 shares during the last quarter. Regent Peak Wealth Advisors LLC boosted its stake in UnitedHealth Group by 21.3% in the second quarter. Regent Peak Wealth Advisors LLC now owns 1,620 shares of the healthcare conglomerate’s stock valued at $673,000 after acquiring an additional 285 shares in the last quarter. Annex Advisory Services LLC lifted its stake in UnitedHealth Group by 159.6% in the second quarter. Annex Advisory Services LLC now owns 68,577 shares of the healthcare conglomerate’s stock valued at $28,503,000 after buying an additional 42,157 shares during the last quarter. Finally, Whitener Capital Management Inc. boosted its stake in shares of UnitedHealth Group by 43.0% during the second quarter. Whitener Capital Management Inc. now owns 3,893 shares of the healthcare conglomerate’s stock worth $1,618,000 after buying an additional 1,171 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on UNH shares. Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, June 23rd. Mizuho set a $493.00 target price on shares of UnitedHealth Group in a research note on Monday. Piper Sandler set a $477.00 price target on shares of UnitedHealth Group in a research note on Thursday. Finally, Robert W. Baird upgraded UnitedHealth Group from an “underperform” rating to a “neutral” rating and upped their target price for the stock from $287.00 to $453.00 in a report on Thursday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $449.17.
Get Our Latest Analysis on UnitedHealth Group
About Representative Newhouse
Dan Newhouse (Republican Party) is a member of the U.S. House, representing Washington’s 4th Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.
Newhouse (Republican Party) ran for re-election to the U.S. House to represent Washington’s 4th Congressional District. He won in the general election on November 5, 2024.
Click here to see Newhouse’s key votes in Congress.
Newhouse served as a member of the Washington House of Representatives representing District 15-Position 2 from 2003 through 2009 and as Washington Director of Agriculture from 2009 to 2013.
Newhouse was first elected to the state House in 2002 and served until he was named state Director of Agriculture in 2009. He was first appointed by Governor Christine Gregoire on February 18, 2009.
UnitedHealth Group Company Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- Oracle Is One Step From Junk—Can It Afford the AI Boom?
- Qualcomm Stock Slides 30%: Buying Opportunity Ahead of July 29 Earnings
- The Ugliest Stocks in the Market Just Got a Very Expensive Vote of Confidence
- Is Domino’s Stock Serving Up a Buying Opportunity?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
